Curaleaf Acquires Four 20 Pharma, Expands European Presence

0:00Cureleaf holdings out of Stanford, locked in the full take over of 420 Pharma, a key German player in medical cannabis production and distribution. They'd held majority controls since 2022. Now snapping up that last 45% stake to own it outright. This deal taps into 420 Pharma's strong network across Germany and other European spots, supplying nursing homes, pharmacies, and research centers. With steady product flow, it bolsters Corral Leafs into end-global supply chain, linking up their cultivation ops in Portugal and Canada for smoother operations worldwide. The company has already pushed the 420 brand into the United Kingdom and Poland with plans to roll it out to even more international markets down. The line. Cureleaf's CEO, Boris Jordan, sees this as a cornerstone of their overseas push, paving the way for serious long-term expansion across Europe. That's your update from Hartford News Today, powered by AI. I'm Corey with The Story.